Portfolio company
Diana Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops PCR diagnostic kits and molecular biology reagents for healthcare providers, pharmaceutical partners and academic laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
DiNona
This company develops monoclonal antibody therapies and rapid diagnostic kits for medical researchers, healthcare providers and pharmaceutical organisations.
MultiplexDX
This company develops molecular diagnostic tests and reagents for oncologists and research institutions to improve cancer profiling and infectious disease detection.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
DENCODA
This biotechnology company develops DNA-linked probes and diagnostic assays for researchers and healthcare providers to detect disease biomarkers and enzyme activities.
Bio-Techne Corporation
This company manufactures life science reagents, analytical instruments and precision diagnostics for academic researchers, biopharmaceutical companies and clinical diagnostic laboratories.
BioSpeedia
This company develops and produces rapid diagnostic kits for infectious diseases for health professionals and clinical diagnostic markets.
